Cargando…
Resistance to thyroid hormone accompanied by atrial fibrillation
Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillatio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169536/ https://www.ncbi.nlm.nih.gov/pubmed/30306779 http://dx.doi.org/10.1530/EDM-18-0100 |
_version_ | 1783360529891328000 |
---|---|
author | Sato, Haruhiro Tomita, Yuichiro |
author_facet | Sato, Haruhiro Tomita, Yuichiro |
author_sort | Sato, Haruhiro |
collection | PubMed |
description | Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillation (AF) complaining of palpitation and general fatigue. Electrocardiography results revealed AF. He exhibited elevated TH levels and an inappropriately normal level of thyroid-stimulating hormone (TSH). Despite being negative for anti-TSH receptor antibody, thyroid-stimulating antibody and anti-thyroperoxidase antibody, the patient was positive for anti-thyroglobulin (Tg) antibody. Genetic analysis of the THRB gene identified a missense mutation, F269L, leading to the diagnosis of RTH. Normal sinus rhythm was achieved after 1 week of oral bisoprolol fumarate (5 mg/day) administration. After 3 years on bisoprolol fumarate, the patient had been doing well with normal sinus rhythm, syndrome of inappropriate secretion of TSH (SITSH) and positive titer of anti-Tg antibody. LEARNING POINTS: Atrial fibrillation can occur in patients with RTH. Only a few cases have been reported on the coexistence of RTH and atrial fibrillation. No consensus exists regarding the management of atrial fibrillation in patients with RTH. Administration of bisoprolol fumarate, a beta-blocker, can ameliorate atrial fibrillation in RTH. |
format | Online Article Text |
id | pubmed-6169536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61695362018-10-10 Resistance to thyroid hormone accompanied by atrial fibrillation Sato, Haruhiro Tomita, Yuichiro Endocrinol Diabetes Metab Case Rep Insight into Disease Pathogenesis or Mechanism of Therapy Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillation (AF) complaining of palpitation and general fatigue. Electrocardiography results revealed AF. He exhibited elevated TH levels and an inappropriately normal level of thyroid-stimulating hormone (TSH). Despite being negative for anti-TSH receptor antibody, thyroid-stimulating antibody and anti-thyroperoxidase antibody, the patient was positive for anti-thyroglobulin (Tg) antibody. Genetic analysis of the THRB gene identified a missense mutation, F269L, leading to the diagnosis of RTH. Normal sinus rhythm was achieved after 1 week of oral bisoprolol fumarate (5 mg/day) administration. After 3 years on bisoprolol fumarate, the patient had been doing well with normal sinus rhythm, syndrome of inappropriate secretion of TSH (SITSH) and positive titer of anti-Tg antibody. LEARNING POINTS: Atrial fibrillation can occur in patients with RTH. Only a few cases have been reported on the coexistence of RTH and atrial fibrillation. No consensus exists regarding the management of atrial fibrillation in patients with RTH. Administration of bisoprolol fumarate, a beta-blocker, can ameliorate atrial fibrillation in RTH. Bioscientifica Ltd 2018-10-01 /pmc/articles/PMC6169536/ /pubmed/30306779 http://dx.doi.org/10.1530/EDM-18-0100 Text en © 2018 The authors http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB) . |
spellingShingle | Insight into Disease Pathogenesis or Mechanism of Therapy Sato, Haruhiro Tomita, Yuichiro Resistance to thyroid hormone accompanied by atrial fibrillation |
title | Resistance to thyroid hormone accompanied by atrial fibrillation |
title_full | Resistance to thyroid hormone accompanied by atrial fibrillation |
title_fullStr | Resistance to thyroid hormone accompanied by atrial fibrillation |
title_full_unstemmed | Resistance to thyroid hormone accompanied by atrial fibrillation |
title_short | Resistance to thyroid hormone accompanied by atrial fibrillation |
title_sort | resistance to thyroid hormone accompanied by atrial fibrillation |
topic | Insight into Disease Pathogenesis or Mechanism of Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169536/ https://www.ncbi.nlm.nih.gov/pubmed/30306779 http://dx.doi.org/10.1530/EDM-18-0100 |
work_keys_str_mv | AT satoharuhiro resistancetothyroidhormoneaccompaniedbyatrialfibrillation AT tomitayuichiro resistancetothyroidhormoneaccompaniedbyatrialfibrillation |